Dramatic Outcomes In Prostate Cancer Study
Friday, June 19, 2009 - 15:14
in Health & Medicine
Two patients whose prostate cancer had been considered inoperable are now cancer free thanks in part to an experimental drug therapy that was used in combination with standardized hormone treatment and radiation therapy. The men were participating in a clinical trial of an immunotherapeutic agent called MDX-010 or ipilimumab.
Read the whole article on Science Daily
More from Science Daily
Related
- Mayo researchers: Dramatic outcomes in prostate cancer studyFri, 19 Jun 2009, 15:11:50 EDT
- New tool helps physicians tailor hormone therapy for high-risk prostate cancer patientsTue, 23 Sep 2008, 14:09:26 EDT
- OHSU Cancer Institute finds that drug stimulated immune system in prostate cancerMon, 2 Jun 2008, 14:14:53 EDT
- Radiation added to hormone therapy increases survival for men with prostate cancerMon, 22 Sep 2008, 8:29:41 EDT
- Study: When/if to start hormones for prostate cancer patients whose PSA rises after radiationTue, 23 Sep 2008, 14:09:18 EDT